Chapter/Section Purchase

1 Soft Tissue Biologics Market Overview
1.1 Product Overview and Scope of Soft Tissue Biologics
1.2 Soft Tissue Biologics Segment by Type
1.2.1 Global Soft Tissue Biologics Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Carpal Soft Tissue
1.2.3 Cubital Soft Tissue
1.2.4 Plantar Fascia Soft Tissue
1.2.5 Gastrocnemius Mollis Soft Tissue
1.2.6 Tarsal Tunnel Soft Tissue
1.2.7 Others
1.3 Soft Tissue Biologics Segment by Application
1.3.1 Global Soft Tissue Biologics Sales Comparison by Application: (2022-2028)
1.3.2 General Hospitals
1.3.3 Speciality Clinics
1.3.4 Others
1.4 Global Soft Tissue Biologics Market Size Estimates and Forecasts
1.4.1 Global Soft Tissue Biologics Revenue 2017-2028
1.4.2 Global Soft Tissue Biologics Sales 2017-2028
1.4.3 Soft Tissue Biologics Market Size by Region: 2017 Versus 2021 Versus 2028
2 Soft Tissue Biologics Market Competition by Manufacturers
2.1 Global Soft Tissue Biologics Sales Market Share by Manufacturers (2017-2022)
2.2 Global Soft Tissue Biologics Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Soft Tissue Biologics Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Soft Tissue Biologics Manufacturing Sites, Area Served, Product Type
2.5 Soft Tissue Biologics Market Competitive Situation and Trends
2.5.1 Soft Tissue Biologics Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Soft Tissue Biologics Players Market Share by Revenue
2.5.3 Global Soft Tissue Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Soft Tissue Biologics Retrospective Market Scenario by Region
3.1 Global Soft Tissue Biologics Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Soft Tissue Biologics Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Soft Tissue Biologics Market Facts & Figures by Country
3.3.1 North America Soft Tissue Biologics Sales by Country
3.3.2 North America Soft Tissue Biologics Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Soft Tissue Biologics Market Facts & Figures by Country
3.4.1 Europe Soft Tissue Biologics Sales by Country
3.4.2 Europe Soft Tissue Biologics Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Soft Tissue Biologics Market Facts & Figures by Region
3.5.1 Asia Pacific Soft Tissue Biologics Sales by Region
3.5.2 Asia Pacific Soft Tissue Biologics Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Soft Tissue Biologics Market Facts & Figures by Country
3.6.1 Latin America Soft Tissue Biologics Sales by Country
3.6.2 Latin America Soft Tissue Biologics Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Soft Tissue Biologics Market Facts & Figures by Country
3.7.1 Middle East and Africa Soft Tissue Biologics Sales by Country
3.7.2 Middle East and Africa Soft Tissue Biologics Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Soft Tissue Biologics Historic Market Analysis by Type
4.1 Global Soft Tissue Biologics Sales Market Share by Type (2017-2022)
4.2 Global Soft Tissue Biologics Revenue Market Share by Type (2017-2022)
4.3 Global Soft Tissue Biologics Price by Type (2017-2022)
5 Global Soft Tissue Biologics Historic Market Analysis by Application
5.1 Global Soft Tissue Biologics Sales Market Share by Application (2017-2022)
5.2 Global Soft Tissue Biologics Revenue Market Share by Application (2017-2022)
5.3 Global Soft Tissue Biologics Price by Application (2017-2022)
6 Key Companies Profiled
6.1 AlloSource
6.1.1 AlloSource Corporation Information
6.1.2 AlloSource Description and Business Overview
6.1.3 AlloSource Soft Tissue Biologics Sales, Revenue and Gross Margin (2017-2022)
6.1.4 AlloSource Soft Tissue Biologics Product Portfolio
6.1.5 AlloSource Recent Developments/Updates
6.2 Arthrex
6.2.1 Arthrex Corporation Information
6.2.2 Arthrex Description and Business Overview
6.2.3 Arthrex Soft Tissue Biologics Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Arthrex Soft Tissue Biologics Product Portfolio
6.2.5 Arthrex Recent Developments/Updates
6.3 ConMed
6.3.1 ConMed Corporation Information
6.3.2 ConMed Description and Business Overview
6.3.3 ConMed Soft Tissue Biologics Sales, Revenue and Gross Margin (2017-2022)
6.3.4 ConMed Soft Tissue Biologics Product Portfolio
6.3.5 ConMed Recent Developments/Updates
6.4 LifeNet Health
6.4.1 LifeNet Health Corporation Information
6.4.2 LifeNet Health Description and Business Overview
6.4.3 LifeNet Health Soft Tissue Biologics Sales, Revenue and Gross Margin (2017-2022)
6.4.4 LifeNet Health Soft Tissue Biologics Product Portfolio
6.4.5 LifeNet Health Recent Developments/Updates
6.5 Smith & Nephew
6.5.1 Smith & Nephew Corporation Information
6.5.2 Smith & Nephew Description and Business Overview
6.5.3 Smith & Nephew Soft Tissue Biologics Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Smith & Nephew Soft Tissue Biologics Product Portfolio
6.5.5 Smith & Nephew Recent Developments/Updates
6.6 Stryker
6.6.1 Stryker Corporation Information
6.6.2 Stryker Description and Business Overview
6.6.3 Stryker Soft Tissue Biologics Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Stryker Soft Tissue Biologics Product Portfolio
6.6.5 Stryker Recent Developments/Updates
6.7 Surgalign Spine Technologies
6.6.1 Surgalign Spine Technologies Corporation Information
6.6.2 Surgalign Spine Technologies Description and Business Overview
6.6.3 Surgalign Spine Technologies Soft Tissue Biologics Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Surgalign Spine Technologies Soft Tissue Biologics Product Portfolio
6.7.5 Surgalign Spine Technologies Recent Developments/Updates
6.8 Zimmer Biomet
6.8.1 Zimmer Biomet Corporation Information
6.8.2 Zimmer Biomet Description and Business Overview
6.8.3 Zimmer Biomet Soft Tissue Biologics Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Zimmer Biomet Soft Tissue Biologics Product Portfolio
6.8.5 Zimmer Biomet Recent Developments/Updates
7 Soft Tissue Biologics Manufacturing Cost Analysis
7.1 Soft Tissue Biologics Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Soft Tissue Biologics
7.4 Soft Tissue Biologics Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Soft Tissue Biologics Distributors List
8.3 Soft Tissue Biologics Customers
9 Soft Tissue Biologics Market Dynamics
9.1 Soft Tissue Biologics Industry Trends
9.2 Soft Tissue Biologics Market Drivers
9.3 Soft Tissue Biologics Market Challenges
9.4 Soft Tissue Biologics Market Restraints
10 Global Market Forecast
10.1 Soft Tissue Biologics Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Soft Tissue Biologics by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Soft Tissue Biologics by Type (2023-2028)
10.2 Soft Tissue Biologics Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Soft Tissue Biologics by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Soft Tissue Biologics by Application (2023-2028)
10.3 Soft Tissue Biologics Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Soft Tissue Biologics by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Soft Tissue Biologics by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer